Find information on Clinical Trials & Early Access Programs:
"I’m determined to make it easier for patients with unmet medical needs and their physicians to find and get access to medicines that are now unavailable to them but could potentially improve their lives.”
Founder & CEO
“I founded myTomorrows to help patients & physicians learn about and find the latest treatments available within Clinical Trials and Early Access Programs.”
Senior Quality Officer
“I believe that patients should be able to get access to other options when they have exhausted regular treatment options. I joined myTomorrows to get medicines that are currently in development to the people in high medical need who want access to them.”
“Working here at myTomorrows, I can go home knowing that what I do at my job means I am helping real people, every day.”
Chief Technology Officer
"As a Computer Scientist, it is very motivating to apply my skills & knowledge directly towards helping patients and physicians navigate the overload of medical data."
What is a Clinical Trial?Go to FAQ
When a pharmaceutical or biotechnology company develops a new medicine, they have to test it extensively to evaluate the effects of the medicine on participants’ health and to make sure it is effective and safe enough for public use. Participating in a Clinical Trial can enable patients to be treated with a medicine before it is approved. There is no guarantee that a medicine which is still in clinical development will improve a patient's condition.
What is an Early Access Program?Go to FAQ
Early Access Programs are programs allowed through a special provision in the law that enables treatment with pre-approval medicines of patients with unmet medical needs that suffer from a life-threatening or debilitating disease and which have exhausted treatment options with approved medication.
Different governments, companies and hospitals may use any of these terms to describe programs that provide access to pre-approval medicines:
- Early Access Program
- Expanded Access Program
- Named Patient
- Named Patient Use
- Named Patient Import
- Named Patient Program
- Investigational Drug
- Managed Access Program
- Patient Specific Drug Import
- Compassionate Use
How is a Clinical Trial different from an Early Access Program?Go to FAQ
The purpose of a Clinical Trial is to test a medicine. The purpose of an Early Access Program is to treat patients with an unmet medical need. An unmet medical need in relation to an Early Access Program means for a patient that there is no approved medicine available, or that they have exhausted all approved medicines available.
Clinical trials normally only take place in a limited number of treating centers in a select number of countries. In theory, Early Access Programs can help patients anywhere.
How do I qualify for an Early Access Program?Go to FAQ
You might qualify for an Early Access Program:
- If you have a life threatening or debilitating disease
- If you have no remaining viable treatment options with registered medicines
- If you cannot enter an available Clinical Trial with the medicine accessible through the Early Access Program
- If your treating physician is willing to prescribe the pre-approval medicine
- If the pharmaceutical company developing the medicine is willing to provide access
- If the authorities approve access to the pre-approval medicine
Why do I need my doctor’s support for an Early Access Program?Go to FAQ
You need your doctor’s support because you will not only need a prescription for the medicine, but your treating doctor understands your full health history and needs. Your doctor also ensures that the pre-approval medicine you would like to be treated with is suitable, can inform you about how the medicine works, and possible risks and side effects.
Can myTomorrows help arrange reimbursement for the medicine?Go to FAQ
Yes, myTomorrows can help to arrange reimbursement for the cost of the medicine. We know from experience how reimbursement systems in many countries work, so we’re ready and able to facilitate this. This often happens on a case-by-case basis. To find out how reimbursement works in your country please contact us.
Find the available treatment options within
Clinical Trials & Early Access Programs
for your medical condition
Your information belongs to you